Cornerstone Advisors LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cornerstone Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,300 shares of the medical equipment provider's stock after purchasing an additional 2,000 shares during the period. Cornerstone Advisors LLC's holdings in Intuitive Surgical were worth $7,025,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Creekmur Asset Management LLC lifted its holdings in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. LRI Investments LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. Finally, LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 0.6 %

NASDAQ ISRG opened at $541.82 on Thursday. The firm has a market cap of $192.99 billion, a PE ratio of 87.11, a price-to-earnings-growth ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $544.38. The company has a 50 day moving average price of $502.44 and a 200 day moving average price of $461.26.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent research reports. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Stifel Nicolaus upped their target price on Intuitive Surgical from $475.00 to $525.00 and gave the company a "buy" rating in a research note on Friday, October 18th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research note on Thursday, October 17th. Finally, Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an "overweight" rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.